On NO-The continuing story of nitric oxide, diabetes, and cardiovascular disease

Diabetes

Volumn 62, Issue 8, 2013, Pages 2645-2647

  Bøtker, Hans Erik ^a   Møller, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; ARGININE; INSULIN; N,N-DIMETHYLARGININE; DRUG DERIVATIVE; N,N DIMETHYLARGININE;

CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL ADHESION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME SYNTHESIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; INTRAVENOUS GLUCOSE TOLERANCE TEST; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TISSUE BLOOD FLOW; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; MALE; METABOLISM; PHYSIOLOGY;

ARGININE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; NITRIC OXIDE;

EID: 84891694685     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0542     Document Type: Note

References (20)

1. Kietadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: New insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 2012;302:E481-E495
2. Muniyappa R, Sowers Jr. Endothelial insulin and IGF-1 receptors: When yes means NO. Diabetes 2012;61:2225-2227
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327: 524-526
5. Yki-Järvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998;41:369-379
6. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070
7. Mather KJ, Steinberg HO, Baron AD. Insulin resistance in the vasculature. J Clin Invest 2013;123:1003-1004
8. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension 2011;57:891-897
9. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012;380:601-610
10. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728
11. Muniyappa R, Sowers Jr. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 2013;14:5-12
12. Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 2010;6:82-90
13. Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov 2011;10:277-291
14. Tessari P, Cecchet D, Artusi C, et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62: 2699-2708
15. Siervo M, Bluck LJ. In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome. Metabolism 2012;61:680-688
16. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulindependent (type II) diabetes mellitus. J Clin Invest 1985;76:149-155
17. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48:1856-1862
18. Title LM, Lonn E, Charbonneau F, et al. Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med 2008;13:263-270
19. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2008; 196:795-802
20. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865